When thalidomide came to market in the 1950s as a morning sickness treatment, no one imagined the many cases of birth defects that would result from use of the drug. More than 50 years later, a small Madison-based stem cell company is selling a research product that could have prevented what some have called one of the biggest medical tragedies of modern times. Read full Journal Sentinel story here.
- WiSys: Tech Council Tom Still joins boardDecember 1, 2020
- ‘WisBiz: The Show’ features Christopher Johnson of Mappix, Tech Metrics and upcoming eventsNovember 30, 2020
- InsideWis: A Thanksgiving week appeal to the great techie in The CloudNovember 24, 2020
- It’s a wrap: 2020 Early Stage Symposium!November 19, 2020
- InsideWis: Cybersecurity worries mount for businesses, health care during transitionNovember 19, 2020